Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Nov 21, 2012 (14 years ago)

Isovue -370

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter; fibers identified as cellulose and polyvinyl

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Isovue -370 (Iopamidol) Injection 76%, Prefilled 10 x 75 mL (NDC 0270-1316-66), 10 x 100 mL (NDC 0270-1316-67), 10 x 125 mL (NDC 0270-1316-68) Power Injector Syringe, Rx Only, Manufactured for Bracco Diagnostics Inc., Princeton, NJ 08543 by Nycomed GmbH 78224 Singen (Germany).

Affected NDCs 0270-1316-66 0270-1316-67 0270-1316-68

Compare with the code on your package — it is the most precise check available.

Drug: Iopamidol

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Isovue 370
Iopamidol
NDC 00270-1316
755 mg/mL Injection, Solution
Intravascular
Bracco Diagnostics Inc Rx
Recalling firm
Bracco Diagnostic Inc
NDC code
0270-1316-66
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-157-2013 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Iopamidol recalls

See all
Class I · High risk

Isovue -300

Presence of Particulate Matter; fibers identified as cellulose and polyvinyl

Terminated Particulate / foreign matter Bracco Diagnostic Inc NDC 0270-1315-67 D-158-2013
Class II · Moderate risk

Iopamidol 41% Injectable 198 Ml 99 Ml 50 Ml 600 Ml 72 Ml

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1549-2012

Other recalls by Bracco Diagnostic Inc

All 2012 recalls
Class III · Low risk

E-Z-HD (barium sulfate)

Subpotent Drug: Low out of specification results for both pH and assay obtained during routine stability testing after 36 months.

Terminated Wrong potency / content Bracco Diagnostic Inc NDC 32909-764-01 D-1536-2014
Class I · High risk

Isovue -300

Presence of Particulate Matter; fibers identified as cellulose and polyvinyl

Terminated Particulate / foreign matter Bracco Diagnostic Inc NDC 0270-1315-67 D-158-2013